Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Directed evolution of Phi29 DNA Polymerase for HNA synthesis

PROVIDER: PRJNA883233 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR21675867_1.fastq.gz	Fastqsanger.gz
	SRR21675867_2.fastq.gz	Fastqsanger.gz
	SRR21675868_1.fastq.gz	Fastqsanger.gz
	SRR21675868_2.fastq.gz	Fastqsanger.gz
	SRR21675869_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 12

Similar Datasets

Single-cell aneuploidy detection by array CGH

Project description:In this study, we extend array CGH technology by making the accurate detection of chromosomal imbalances possible from a single fibroblast and blastomere following Phi29 DNA polymerase amplification. Keywords: CGH

2006-02-01 | GSE3642 | GEO

Single-cell chromosomal imbalances detection by array CGH

Project description:In this study, we extend array CGH technology by making the accurate detection of segmental aneusomies possible from a single lymphoblast and fibroblast following Phi29 DNA polymerase amplification Keywords: array CGH, aCGH

2006-02-16 | GSE4244 | GEO

Project description:KOD DNA Polymerase Directed Evolution for Intramolecular Network Reconstruction

| PRJNA1107809 | ENA

Project description:KOD DNA Polymerase Directed Evolution - Optimization of selection parameters

| PRJNA1096033 | ENA

Amplification of whole tumor genomes and gene-by-gene mapping of genomic aberrations from limited sources of DNA

Project description:This SuperSeries is composed of the following subset Series: GSE4078: Phi29-based amplification of fresh-frozen and FFPE tumor DNA GSE4079: Genome-Wide Gene Dosage Representation in Phi29-Amplified DNA Abstract: Sufficient quantity of genomic DNA can be a bottleneck in genome-wide analysis of clinical tissue samples. DNA polymerase Phi29 can be used for the random-primed amplification of whole genomes, although the amplification may introduce bias in gene dosage. We have performed a detailed investigation of this technique in archival fresh-frozen and formalin-fixed/paraffin-embedded tumor DNA by using cDNA microarray-based comparative genomic hybridization. Phi29 amplified DNA from matched pairs of fresh-frozen and formalin-fixed/paraffin-embedded tumor samples with similar efficiency. The distortion in gene dosage representation in the amplified DNA was nonrandom and reproducibly involved distinct genomic loci. Regional amplification efficiency was significantly linked to regional GC content of the template genome. The biased gene representation in amplified tumor DNA could be effectively normalized by using amplified reference DNA. Our data suggest that genome-wide gene dosage alterations in clinical tumor samples can be reliably assessed from a few hundred tumor cells. Therefore, this amplification method should lend itself to high-throughput genetic analyses of limited sources of tumor, such as fine-needle biopsies, laser-microdissected tissue, and small paraffin-embedded specimens. Refer to individual Series

2006-03-14 | E-GEOD-4467 | biostudies-arrayexpress

Homo sapiens

Project description:DNA polymerase Lambda-driven targeted mutagenesis for directed evolution in human cells

| PRJNA1136418 | ENA

Amplification of whole tumor genomes and gene-by-gene mapping of genomic aberrations from limited sources of DNA

Project description:Abstract: Sufficient quantity of genomic DNA can be a bottleneck in genome-wide analysis of clinical tissue samples. DNA polymerase Phi29 can be used for the random-primed amplification of whole genomes, although the amplification may introduce bias in gene dosage. We have performed a detailed investigation of this technique in archival fresh-frozen and formalin-fixed/paraffin-embedded tumor DNA by using cDNA microarray-based comparative genomic hybridization. Phi29 amplified DNA from matched pairs of fresh-frozen and formalin-fixed/paraffin-embedded tumor samples with similar efficiency. The distortion in gene dosage representation in the amplified DNA was nonrandom and reproducibly involved distinct genomic loci. Regional amplification efficiency was significantly linked to regional GC content of the template genome. The biased gene representation in amplified tumor DNA could be effectively normalized by using amplified reference DNA. Our data suggest that genome-wide gene dosage alterations in clinical tumor samples can be reliably assessed from a few hundred tumor cells. Therefore, this amplification method should lend itself to high-throughput genetic analyses of limited sources of tumor, such as fine-needle biopsies, laser-microdissected tissue, and small paraffin-embedded specimens. This SuperSeries is composed of the SubSeries listed below.

2006-03-15 | GSE4467 | GEO

DNA-directed termination of RNA Polymerase II transcription

Project description:DNA-directed termination of RNA Polymerase II transcription

| PRJNA906143 | ENA

DNA polymerase η contributes to lagging strand synthesis

Project description:DNA polymerase η contributes to lagging strand synthesis

| PRJNA433239 | ENA

DNA-directed termination of RNA Polymerase II transcription I

Project description:DNA-directed termination of RNA Polymerase II transcription I

| PRJNA906145 | ENA